# Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study

> **NCT01862861** · — · COMPLETED · sponsor: **Medimix Specialty Pharmacy, LLC** · enrollment: 69 (actual)

## Conditions studied

- Menopause

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01862861
- **Lead sponsor:** Medimix Specialty Pharmacy, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01862861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01862861, "Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01862861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*